Plasmodium malariae infection in spite of previous anti-malarial medication

Parasitol Res. 2008 Feb;102(3):547-50. doi: 10.1007/s00436-007-0804-4. Epub 2007 Dec 2.

Abstract

Plasmodium malariae is regarded as usually being susceptible to all anti-malarials whether applied for prophylaxis or treatment. We report on three cases of P. malariae infection which occurred 12-14 weeks after anti-malarial chemoprophylaxis or treatment with mefloquine or atovaquone/proguanil. The most likely explanation for the failure of mefloquine and atovaquone/proguanil to prevent quartan malaria occurring some months later is the insufficient effect on the particularly long-lasting pre-erythrocytic development stages of P. malariae.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Animals
  • Antimalarials / therapeutic use*
  • DNA, Protozoan / genetics
  • DNA, Protozoan / isolation & purification
  • Germany
  • Ghana
  • Humans
  • Kenya
  • Malaria / diagnosis*
  • Malaria / drug therapy
  • Male
  • Middle Aged
  • Plasmodium malariae / genetics
  • Plasmodium malariae / pathogenicity*
  • Polymerase Chain Reaction
  • Travel

Substances

  • Antimalarials
  • DNA, Protozoan